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Background 
Pneumonia causes many deaths in children under five. 
Vitamin A reduces mortality in children with pneumonia 
and measles together. This review examines whether a 
similar effect occurs with non-measles pneumonia. 
Inclusion criteria 
Studies:  
Randomized controlled trials (RCTs) and quasi-RCTs. 
Participants: 
Children under 15 years old with pneumonia unrelated 
to measles. 
Intervention: 
Intervention: vitamin A plus standard treatment. 
Control: standard treatment, with or without placebo. 
Outcomes: 
Primary: death.  
Other: signs of pneumonia (including fever, chest x-ray 
findings); clinical severity (including oxygen saturation, 
bronchial breathing, duration of hospitalization); adverse 
events following vitamin A intake. 
Results 
• Five RCTs and one quasi-RCT were included, 
involving 1740 infants and children. Allocation 
concealment was adequate in three trials. 
• No statistically significant difference was detected 
between vitamin A and placebo in relation to death 
during hospital stay (1146 participants, 3 trials), 
duration of fever (958 participants, 3 trials), or 
antibiotic failure (472 participants, 1 trial). 
• Three trials reported minor and transitory adverse 
effects of Vitamin A.  
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Should vitamin A be given routinely to children with  
pneumonia unrelated to measles? 
There is not enough evidence to recommend routine vitamin A in children 
with  pneumonia unrelated to measles. 
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Authors’ conclusions 
Implications for practice:  
There is insufficient evidence of clinical benefit to recommend vitamin A routinely in children with pneumonia 
unrelated to measles. 
Implications for research: 
The small size of the trials and variability in the measured outcomes limited the power of the meta-analyses. Large, 
well-designed trials examining the effectiveness and safety of vitamin A for children with non-measles pneumonia 
are needed. Trials should evaluate the effects of vitamin A in children at both high and low risk of deficiency, and 
examine different vitamin A doses to optimise possible benefits for children with non-measles pneumonia.  
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